Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bjarnason

Showing results (11-20 of 171) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|December 16, 1995
NSAIDs, Cox-2 inhibitors, and the gutJ Hayllar, I Bjarnason
The Italian Journal of Gastroenterology|December 1, 1996
Early pathogenic events in NSAID-induced gastrointestinal damageI Bjarnason, J Hayllar
The Italian Journal of Gastroenterology|December 1, 1996
Gastroduodenal tolerability of highly specific cyclo-oxygenase-2 inhibitorJ Hayllar, I Bjarnason
Gut|November 1, 1993
Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowelK Teahon, I Bjarnason
Journal of Pediatric Gastroenterology and Nutrition|August 2, 2001
Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammationI Bjarnason, R Sherwood
Pharmacoeconomics|December 9, 1992
NSAIDS and gastropathyA Macpherson, I Bjarnason
Postgraduate Medical Journal|March 7, 2006
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?D Adebayo, I Bjarnason
Gut|May 1, 1991
Sulphasalazine in ulcerative colitis: in memoriam?J Hayllar, I Bjarnason
Gut|October 1, 1990
Experience with a gastrointestinal marker (51CrCl3) in a combined study of ileal function using 75SeHCAT and 58CoB12 measured by whole body countingT Smith, I Bjarnason
Gut|March 1, 1988
Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitisI Bjarnason, K Middleton
Pageof 18

Showing results (11-20 of 171) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|December 16, 1995
NSAIDs, Cox-2 inhibitors, and the gutJ Hayllar, I Bjarnason
The Italian Journal of Gastroenterology|December 1, 1996
Early pathogenic events in NSAID-induced gastrointestinal damageI Bjarnason, J Hayllar
The Italian Journal of Gastroenterology|December 1, 1996
Gastroduodenal tolerability of highly specific cyclo-oxygenase-2 inhibitorJ Hayllar, I Bjarnason
Gut|November 1, 1993
Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowelK Teahon, I Bjarnason
Journal of Pediatric Gastroenterology and Nutrition|August 2, 2001
Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammationI Bjarnason, R Sherwood
Pharmacoeconomics|December 9, 1992
NSAIDS and gastropathyA Macpherson, I Bjarnason
Postgraduate Medical Journal|March 7, 2006
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?D Adebayo, I Bjarnason
Gut|May 1, 1991
Sulphasalazine in ulcerative colitis: in memoriam?J Hayllar, I Bjarnason
Gut|October 1, 1990
Experience with a gastrointestinal marker (51CrCl3) in a combined study of ileal function using 75SeHCAT and 58CoB12 measured by whole body countingT Smith, I Bjarnason
Gut|March 1, 1988
Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitisI Bjarnason, K Middleton
Pageof 18